RE:RE: Oh, Oh - avoid this stock ?quinlash wrote: Keeler,
First off you have provided no link to what you are trying to pass off as an article.
Secondly, HEXO has posted (on average) losses of 20 - 25 Million per QTR over the last 4 QTRs / 1 year, this (on the high side) if you total it is 100 Million.
Lastly, the company has already stated that it will be doing a capital raise to address the Redecan deal as well as debt. A captial raise has a total interest rate applied of ... ZERO PERCENT. As we have yet to see cost per share and QTY for the capitial raise we cannot evaluate the amount of dilution that will come along with that. Considering the Redecan deal is valued at $7.53 per share we can likely take it for granted that the capitial raise will be around that level, or higher, considering the company has (in 2020) raised captial over market during the worse year on record for the cannabis sector.
Please do better research when trying to instill fear in our longs... what you are doing is not working well.
All the best
Q
The Redecan deal is not value at $7.53 per share but at $7.53 per share + $400 millions in cash.